It comes after an evaluation last month was published in which the primary medical officer of England, Sally Davies, concluded there was evidence of “healing benefit” for some conditions.
What do you consider legalising marijuana in the UK?
The home secretary stated: “Current cases including ill children made it clear to me that we had to take a fresh appearance at the scheduling of cannabis-related medicinalproducts.
” I want to thank the chief medical advisor for her initial review and have actually now asked my independent advisory committee to commence the second stage of this procedure. When I have actually gotten its recommendations I will consider what next steps have to be taken.”
The cases that got the most attention concentrated on 12-year-old Billy Caldwell and Alfie Dingley, 6, who have kinds of intractable epilepsy that seem alleviated by the use of cannabis oil.
The Home Office has rubber-stamped an unique exemption licence meaning Billy can go home with his medical cannabis.
Alfie and Billy are among about 20,000 children who do not respond to the medication recommended by the NHS.
The prime minister’s official representative said: “Prof Dame Sally Davies analyzed existing research into therapeutic and medicinal advantages of cannabis-related products. This has led today to the commissioning of the second part of the evaluation that will be completed by the Advisory Council on the Misuse of Drugs.” The ACMD will be recommending on whether cannabis-related medicinal items should be rescheduled within the next three weeks.”
Davies said: “There is clear evidence from highly respected and relied on research study organizations that some cannabis-based medicinal items have therapeutic benefits for some medical conditions.
” As schedule 1 drugs by definition have little or no restorative potential, it is for that reason now clear that from a clinical point of view keeping cannabis-based medical items in schedule 1 is very hard to defend.
Is it time to legalise medical cannabis in the UK?
” Let me be emphatic: this report does not look at leisure cannabis use and does not back or condone leisure usage. There is well-established evidence on the possible harm of leisure marijuana use. This is about helping clients, in extraordinary situations, get access to treatment which might work.”
Val Curran, the professor of psychopharmacology at University College London, invited Javid’s initiative and said she hoped development would be made as a result of the two evaluations.
” Regulations around medications are made complex,” she said. “We did recommend that schedule 2 would be the right schedule however other things need to occur in terms of getting the product readily available and issues about purity.”
Cannabis is presently a schedule 1 drug, which indicates it is believed to have no therapeutic value and can not be lawfully had or prescribed. It can be utilized for the purposes of research but an Office licence is required.
” It’s a bit of a catch 22 … If you can not do research study on it, it’s hard to investigate its medical usage. Something like heroin is schedule 2 as it does have a medical use,” Curran said.
The prime minister’s main spokesman was asked whether the modifications would lead to reclassification, to which they responded: “No this is rescheduling. Set up 1 drugs are those that have little or no therapeutic capacity. We are taking a look at whether we move cannabis into another schedule that makes it easier to be prescribed.
” Leisure use of marijuana will stay illegal; this is looking at how it could be made available as a healing treatment.”
__ action– bottom social-icon-wrapper “href=” https://www.facebook.com/dialog/share?app_id=180444840287&href=https%3A%2F%2Fwww.theguardian.com%2Fsociety%2F2018%2Fjul%2F03%2Fsajid-javid-looks-into-easing-rules-on-medical-cannabis-prescription%3FCMP%3Dshare_btn_fb” target
=” _ blank” title=”Facebook” > Share on Facebook.
Share on Twitter. Share via Email. Share on LinkedIn. Share on Pinterest. Share on Google +. Share on WhatsApp. Share on Messenger. Reuse this material.